BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191107T110000
DTEND;TZID=America/New_York:20191107T180000
DTSTAMP:20190816T160211Z
CREATED:20190816T152142Z
LAST-MODIFIED:20190816T160211Z
UID:6226-1573124400-1573149600@scienceinboston.com
SUMMARY:Discover Brigham
DESCRIPTION:An event to educate and inspire collaboration around innovative science\, technology\, and medicine at Brigham and Women’s Hospital. This event is free and open to the public – all are welcome to attend. \nPlease visit our website for more details: www.discoverbrigham.org.
URL:https://scienceinboston.com/event/discover-brigham/
LOCATION:Brigham and Women’s Hospital\, 75 Francis Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191107T110000
DTEND;TZID=America/New_York:20191107T180000
DTSTAMP:20190816T152142Z
CREATED:20190816T152142Z
LAST-MODIFIED:20190816T152142Z
UID:27322-1573124400-1573149600@scienceinboston.com
SUMMARY:Discover Brigham
DESCRIPTION:An event to educate and inspire collaboration around innovative science\, technology\, and medicine at Brigham and Women’s Hospital. This event is free and open to the public – all are welcome to attend. \nPlease visit our website for more details: www.discoverbrigham.org.
URL:https://scienceinboston.com/event/discover-brigham-2/
LOCATION:Brigham and Women’s Hospital\, 75 Francis Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191106T090000
DTEND;TZID=America/New_York:20191107T170000
DTSTAMP:20191021T140217Z
CREATED:20191021T140217Z
LAST-MODIFIED:20191021T140217Z
UID:6904-1573030800-1573146000@scienceinboston.com
SUMMARY:Challenges in Rare Disease Clinical Trials Symposium & East Training
DESCRIPTION:Description\nSince 2011\, the Complex Innovative Trial Design Symposium and East User Training has brought together industry experts\, thought leaders and applied statisticians to discuss innovations in clinical trials and guide the development of the industry’s leading clinical trial design software\, East. \nThis year we’re proud to be partnering with Alexion to share expertise and ideas surrounding the challenges in rare disease clinical trials. \nWe’re excited to share with you the full list of speakers presenting. Click here to learn more about the speakers and access the presentation abstracts. \nDay 1 Symposium \n8:00AM – 9:00AM \nRegistration and Coffee \n9:00AM – 9:15AM \nWelcome from the Scientific Committee \n9:15AM – 10:15AM \nDrug Development in Rare Diseases – Need for Innovation in Statistical Thinking \nKannan Natarajan\, Pfizer \n10:15AM – 11:00AM \nChallenges in Rare Diseases: The PREVENT Trial for NMSOD \nAmy Pace\, Alexion \n11:00AM – 11:45AM \nHistorical Control Borrowing: Overview\, Advancement and New Methodologies \nJianchang Lin\, Takeda \n11:45AM – 12:45PM \nLunch \n12:45PM – 1:15PM \nCytel Innovations/Roadmap \nGeoffrey Grove\, Cytel \n1:15PM – 2:15PM \nTBC \n2:15PM – 3:00PM \nData Monitoring Committees – Behind Closed Doors \nDavid Kerr\, Axio \n3:00PM – 3:15PM \nBreak \n3:15PM – 4:00PM \nThe Use of Natural History Data in Clinical Trials with Rare Diseases \nClare Elkins\, Alexion \n4:00PM – 4:45PM \nUsing Historical Control for Regulatory Approvals in US – A Practical Review Focusing on Diseases in Small Population \nZiliang Li and Chenkun Wang\, Vertex \n4:45PM – 5:00PM \nClosing Remarks \nDay 2: East Software Training with Pantelis Vlachos\, Principal\, Strategic Consulting \n8:00AM – 9:00AM \nBreakfast and Introduction to East \n9:00AM – 10:45AM \nPhase 1 Dose Escalation (ESCALATE) with Cohort Expansion (PROGRAM) \n10:45AM – 11:00AM \nCoffee Break \n11:00AM – 12:00PM \nPhase 2: MCPMod (Design and Analysis) \n12:00PM – 1:00PM \nLunch and Networking \n1:00PM – 2:00PM \nPhase 2/3: Multi-Arm\, Multiple-Stage Designs (MAMS) \n2:00PM – 3:00PM \nPhase 3: Group Sequential Designs (SURVIVAL) \n3:00PM – 3:15PM \nBreak \n3:15PM – 4:15PM \nPhase 3: Adaptive Designs: Sample Size Re-estimation (SURVADAPT) \n4:15PM – 5:00PM \nPhase 3: Adaptive Population Enrichment (ENRICH) \nEmail sean.cronin@cytel.com if you have any questions.
URL:https://scienceinboston.com/event/challenges-in-rare-disease-clinical-trials-symposium-east-training/
LOCATION:Alexion Pharmaceuticals Inc.\, 121 Seaport Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191106T090000
DTEND;TZID=America/New_York:20191107T170000
DTSTAMP:20191021T140217Z
CREATED:20191021T140217Z
LAST-MODIFIED:20191021T140217Z
UID:27356-1573030800-1573146000@scienceinboston.com
SUMMARY:Challenges in Rare Disease Clinical Trials Symposium & East Training
DESCRIPTION:Description\nSince 2011\, the Complex Innovative Trial Design Symposium and East User Training has brought together industry experts\, thought leaders and applied statisticians to discuss innovations in clinical trials and guide the development of the industry’s leading clinical trial design software\, East. \nThis year we’re proud to be partnering with Alexion to share expertise and ideas surrounding the challenges in rare disease clinical trials. \nWe’re excited to share with you the full list of speakers presenting. Click here to learn more about the speakers and access the presentation abstracts. \nDay 1 Symposium \n8:00AM – 9:00AM \nRegistration and Coffee \n9:00AM – 9:15AM \nWelcome from the Scientific Committee \n9:15AM – 10:15AM \nDrug Development in Rare Diseases – Need for Innovation in Statistical Thinking \nKannan Natarajan\, Pfizer \n10:15AM – 11:00AM \nChallenges in Rare Diseases: The PREVENT Trial for NMSOD \nAmy Pace\, Alexion \n11:00AM – 11:45AM \nHistorical Control Borrowing: Overview\, Advancement and New Methodologies \nJianchang Lin\, Takeda \n11:45AM – 12:45PM \nLunch \n12:45PM – 1:15PM \nCytel Innovations/Roadmap \nGeoffrey Grove\, Cytel \n1:15PM – 2:15PM \nTBC \n2:15PM – 3:00PM \nData Monitoring Committees – Behind Closed Doors \nDavid Kerr\, Axio \n3:00PM – 3:15PM \nBreak \n3:15PM – 4:00PM \nThe Use of Natural History Data in Clinical Trials with Rare Diseases \nClare Elkins\, Alexion \n4:00PM – 4:45PM \nUsing Historical Control for Regulatory Approvals in US – A Practical Review Focusing on Diseases in Small Population \nZiliang Li and Chenkun Wang\, Vertex \n4:45PM – 5:00PM \nClosing Remarks \nDay 2: East Software Training with Pantelis Vlachos\, Principal\, Strategic Consulting \n8:00AM – 9:00AM \nBreakfast and Introduction to East \n9:00AM – 10:45AM \nPhase 1 Dose Escalation (ESCALATE) with Cohort Expansion (PROGRAM) \n10:45AM – 11:00AM \nCoffee Break \n11:00AM – 12:00PM \nPhase 2: MCPMod (Design and Analysis) \n12:00PM – 1:00PM \nLunch and Networking \n1:00PM – 2:00PM \nPhase 2/3: Multi-Arm\, Multiple-Stage Designs (MAMS) \n2:00PM – 3:00PM \nPhase 3: Group Sequential Designs (SURVIVAL) \n3:00PM – 3:15PM \nBreak \n3:15PM – 4:15PM \nPhase 3: Adaptive Designs: Sample Size Re-estimation (SURVADAPT) \n4:15PM – 5:00PM \nPhase 3: Adaptive Population Enrichment (ENRICH) \nEmail sean.cronin@cytel.com if you have any questions.
URL:https://scienceinboston.com/event/challenges-in-rare-disease-clinical-trials-symposium-east-training-2/
LOCATION:Alexion Pharmaceuticals Inc.\, 121 Seaport Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191106T080000
DTEND;TZID=America/New_York:20191106T170000
DTSTAMP:20191021T135316Z
CREATED:20191021T135316Z
LAST-MODIFIED:20191021T135316Z
UID:6900-1573027200-1573059600@scienceinboston.com
SUMMARY:MedTech Entrepreneurs Bootcamp Powered by MassMEDIC
DESCRIPTION:A one-day\, hands-on workshop for medtech\, digital health founders\, brought to you by MassMEDIC\, Ximedica and Ravenoye Group.\n\n\n\n\n\n\nAbout this Event\n\n\nLEARN FROM ACTUAL ENTREPRENEURS\nThe purpose of this one-day boot camp is to educate current and potential founders and entrepreneurs on the best practices of building a medical device company\, through short sessions and personal stories from those who have done it before. \n\nHow to prepare to be and Entrepreneur AND a Founder\nTips on the best way to fund early stage medtech ventures\nStrategies for successful reimbursement strategies in today’s environment\nStrategies on building a human factors plan\nTips on how to pick the right supplier partners\n\nHear personal experiences\, build your investor network\, and gain insight from key industry thought leaders.\nPreliminary Agenda \n9:00: Welcome \n9:30 – 10:15: How to Prepare to be a medtech founder \n10:15 – 10:30 break / networking \n10:30-11:15: What Investors really want to see \n11:15 – 12:00 How to define and accelerate your path from idea to market \n12:00 – 1:00: Lunch / networking \n1:00-1:45: Regulatory\, Clinical Trials\, and Reimbursement Strategy; the good\, the bad\, the ugly \n1:45-2:30: Why you need to build a Human Factors Plan sooner than later \n2:30- 3:00 Supply Chain Management \n3:00: Closing Remarks \nThis event is for founders and members of the start-up community only. We ask that no service providers register for this program.
URL:https://scienceinboston.com/event/medtech-entrepreneurs-bootcamp-powered-by-massmedic/
LOCATION:CIC Providence\, 225 Dyer Street\, Providence\, RI\, 02903\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191106T080000
DTEND;TZID=America/New_York:20191106T170000
DTSTAMP:20191021T135316Z
CREATED:20191021T135316Z
LAST-MODIFIED:20191021T135316Z
UID:27355-1573027200-1573059600@scienceinboston.com
SUMMARY:MedTech Entrepreneurs Bootcamp Powered by MassMEDIC
DESCRIPTION:A one-day\, hands-on workshop for medtech\, digital health founders\, brought to you by MassMEDIC\, Ximedica and Ravenoye Group.\n\n\n\n\n\n\nAbout this Event\n\n\nLEARN FROM ACTUAL ENTREPRENEURS\nThe purpose of this one-day boot camp is to educate current and potential founders and entrepreneurs on the best practices of building a medical device company\, through short sessions and personal stories from those who have done it before. \n\nHow to prepare to be and Entrepreneur AND a Founder\nTips on the best way to fund early stage medtech ventures\nStrategies for successful reimbursement strategies in today’s environment\nStrategies on building a human factors plan\nTips on how to pick the right supplier partners\n\nHear personal experiences\, build your investor network\, and gain insight from key industry thought leaders.\nPreliminary Agenda \n9:00: Welcome \n9:30 – 10:15: How to Prepare to be a medtech founder \n10:15 – 10:30 break / networking \n10:30-11:15: What Investors really want to see \n11:15 – 12:00 How to define and accelerate your path from idea to market \n12:00 – 1:00: Lunch / networking \n1:00-1:45: Regulatory\, Clinical Trials\, and Reimbursement Strategy; the good\, the bad\, the ugly \n1:45-2:30: Why you need to build a Human Factors Plan sooner than later \n2:30- 3:00 Supply Chain Management \n3:00: Closing Remarks \nThis event is for founders and members of the start-up community only. We ask that no service providers register for this program.
URL:https://scienceinboston.com/event/medtech-entrepreneurs-bootcamp-powered-by-massmedic-2/
LOCATION:CIC Providence\, 225 Dyer Street\, Providence\, RI\, 02903\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191106T080000
DTEND;TZID=America/Vancouver:20191106T163000
DTSTAMP:20191021T135118Z
CREATED:20191021T135118Z
LAST-MODIFIED:20191021T135118Z
UID:6897-1573027200-1573057800@scienceinboston.com
SUMMARY:Patient Advocacy Summit 2019
DESCRIPTION:One of MassBio’s most popular events of the year\, the Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization\, but throughout the drug development cycle. \nThis year we’ll explore competing views on what value therapies bring to various stakeholders\, what a cure is worth to patients and society\, how to improve the clinical trial experience for patients\, and more. We will also have a frank discussion about patient access in the era of transformative therapies\, and you’ll hear directly from patients on what this means to them. \nThe program includes panel discussions\, case study presentations(spotlighting industry/patient partnerships)\, an inspirational keynote address\, as well as a networking lunch and cocktail reception. \nSee sponsorship opportunities here\, or contact Laura Rudberg.
URL:https://scienceinboston.com/event/patient-advocacy-summit-2019/
LOCATION:Marriott Boston Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191106T080000
DTEND;TZID=America/Vancouver:20191106T163000
DTSTAMP:20191021T135118Z
CREATED:20191021T135118Z
LAST-MODIFIED:20191021T135118Z
UID:27354-1573027200-1573057800@scienceinboston.com
SUMMARY:Patient Advocacy Summit 2019
DESCRIPTION:One of MassBio’s most popular events of the year\, the Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization\, but throughout the drug development cycle. \nThis year we’ll explore competing views on what value therapies bring to various stakeholders\, what a cure is worth to patients and society\, how to improve the clinical trial experience for patients\, and more. We will also have a frank discussion about patient access in the era of transformative therapies\, and you’ll hear directly from patients on what this means to them. \nThe program includes panel discussions\, case study presentations(spotlighting industry/patient partnerships)\, an inspirational keynote address\, as well as a networking lunch and cocktail reception. \nSee sponsorship opportunities here\, or contact Laura Rudberg.
URL:https://scienceinboston.com/event/patient-advocacy-summit-2019-2/
LOCATION:Marriott Boston Cambridge\, 50 Broadway\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191105T180000
DTEND;TZID=America/New_York:20191105T200000
DTSTAMP:20191021T134936Z
CREATED:20191021T134936Z
LAST-MODIFIED:20191021T134936Z
UID:6894-1572976800-1572984000@scienceinboston.com
SUMMARY:Alexion Research: Building a Pipeline to Service Patients with Rare Disease
DESCRIPTION:BioXchange and Alexion Pharmaceuticals Present: Sharon Barr; VP\, Global Head of Research at Alexion Pharmaceuticals\n\n\n\n\n\n\nAbout this Event\n\n\n\nThis event is one of two sessions: \nBoston\, MA – November 5th \nNew Haven\, CT – November 12th \nOverview: \nSharon Barr; VP\, Global Head of Research at Alexion Pharmaceuticals; will provide an overview of Alexion Pharmaceuticals and the overall company culture. Along with this\, she will go into a deep discussion with regards to the research the company is currently working on within the rare disease space. \nEvent Agenda: \n6:00PM to 7:00PM – Sharon will discuss what Alexion Pharmaceuticals is doing in terms of research in the rare disease space. This will be followed by a short Q&A session with audience. \n7:00PM to 8:00PM – Networking session with light appetizers provided. \n* Registration does not guarantee your admittance into the event due to the high demand expected. We will personally notify those we are able to accommodate for the event. Either way\, please follow us for details on future events. \n** No walk-ins will be admitted. You must RSVP in order to attend. \nMore on the event organizers: \nAbout BioXchange \nBioXchange is a premier life sciences networking organization founded by some of the most networked people in the Boston life sciences hub. Our goal is to help connect companies and individuals within the epicenter of life sciences industry located in Massachusetts through monthly events. Events are typically held in the two largest concentrated areas for life sciences companies: Cambridge and Waltham. These events are setup to cater to all sectors of the industry from scientists\, law firms\, service companies\, staffing firms\, and many others. \nFeel free to reach out to us directly if you have any questions or concerns at bioxchange.boston@gmail.com. \nAbout Alexion Pharmaceuticals \nAlexion Pharmaceuticals is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery\, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years\, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS)\, anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders\, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition\, the company is developing several mid-to-late-stage therapies\, including a second complement inhibitor\, a copper-binding agent for Wilson disease and an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases as well as several early-stage therapies\, including one for light chain (AL) amyloidosis and a second anti-FcRn therapy. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology\, nephrology\, neurology\, and metabolic disorders. Alexion has been named to the Forbes’ list of the World’s Most Innovative Companies seven years in a row and is headquartered in Boston\, Massachusetts’ Innovation District. The company also has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
URL:https://scienceinboston.com/event/alexion-research-building-a-pipeline-to-service-patients-with-rare-disease/
LOCATION:Alexion Pharmaceuticals Inc.\, 121 Seaport Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191105T180000
DTEND;TZID=America/New_York:20191105T200000
DTSTAMP:20191021T134936Z
CREATED:20191021T134936Z
LAST-MODIFIED:20191021T134936Z
UID:27353-1572976800-1572984000@scienceinboston.com
SUMMARY:Alexion Research: Building a Pipeline to Service Patients with Rare Disease
DESCRIPTION:BioXchange and Alexion Pharmaceuticals Present: Sharon Barr; VP\, Global Head of Research at Alexion Pharmaceuticals\n\n\n\n\n\n\nAbout this Event\n\n\n\nThis event is one of two sessions: \nBoston\, MA – November 5th \nNew Haven\, CT – November 12th \nOverview: \nSharon Barr; VP\, Global Head of Research at Alexion Pharmaceuticals; will provide an overview of Alexion Pharmaceuticals and the overall company culture. Along with this\, she will go into a deep discussion with regards to the research the company is currently working on within the rare disease space. \nEvent Agenda: \n6:00PM to 7:00PM – Sharon will discuss what Alexion Pharmaceuticals is doing in terms of research in the rare disease space. This will be followed by a short Q&A session with audience. \n7:00PM to 8:00PM – Networking session with light appetizers provided. \n* Registration does not guarantee your admittance into the event due to the high demand expected. We will personally notify those we are able to accommodate for the event. Either way\, please follow us for details on future events. \n** No walk-ins will be admitted. You must RSVP in order to attend. \nMore on the event organizers: \nAbout BioXchange \nBioXchange is a premier life sciences networking organization founded by some of the most networked people in the Boston life sciences hub. Our goal is to help connect companies and individuals within the epicenter of life sciences industry located in Massachusetts through monthly events. Events are typically held in the two largest concentrated areas for life sciences companies: Cambridge and Waltham. These events are setup to cater to all sectors of the industry from scientists\, law firms\, service companies\, staffing firms\, and many others. \nFeel free to reach out to us directly if you have any questions or concerns at bioxchange.boston@gmail.com. \nAbout Alexion Pharmaceuticals \nAlexion Pharmaceuticals is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery\, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years\, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS)\, anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders\, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition\, the company is developing several mid-to-late-stage therapies\, including a second complement inhibitor\, a copper-binding agent for Wilson disease and an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases as well as several early-stage therapies\, including one for light chain (AL) amyloidosis and a second anti-FcRn therapy. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology\, nephrology\, neurology\, and metabolic disorders. Alexion has been named to the Forbes’ list of the World’s Most Innovative Companies seven years in a row and is headquartered in Boston\, Massachusetts’ Innovation District. The company also has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
URL:https://scienceinboston.com/event/alexion-research-building-a-pipeline-to-service-patients-with-rare-disease-2/
LOCATION:Alexion Pharmaceuticals Inc.\, 121 Seaport Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191105T103000
DTEND;TZID=America/New_York:20191105T143000
DTSTAMP:20191021T134627Z
CREATED:20191021T134627Z
LAST-MODIFIED:20191021T134627Z
UID:6890-1572949800-1572964200@scienceinboston.com
SUMMARY:Mansfield Bio-Incubator's Second Annual Open House
DESCRIPTION:Overview\n\n  \nMansfield Bio-Incubator invites you to attend its second annual Open House on November 5\, 2019 in Mansfield\, Massachusetts. Come join in the fun and see how innovative startup companies are transforming the world with game-changing inventions in life science! \nOver the past year\,  we have added several new exciting startups while our resident companies have been growing and made progress in their research. \nWe are now gearing to expand beyond our 10\,000 sqft space. Up to 1M sqft of the R&D and manufacturing space is planned to house both earlier-stage and mature life science companies. In this way\, we are catalyzing the transformation of the entire 63-acre former glass bottling factory into a 21st century LIfe Science R&D and manufacturing campus. \nSee more information here! \nThis transformation is all due to the cutting edge science and product development going on in the proof of concept laboratories in the incubator.  We have nucleated the life science ecosystem South of Boston and the success is due to you! \nCome see for yourself that the biotechnology supercluster extends along the South of Boston innovation corridor right here to Mansfield\, Massachusetts. Join in the celebration and envision a future for yourself and your company alongside these pioneers. \nYou are invited to celebrate\, connect and launch! Collaborators\, investments and companies are all right here waiting to meet you. If you are working to find a cure for cancer\, detect disease earlier than ever before or treat diseases that have long been neglected\, you will find a home right here at the Mansfield Bio-Incubator. With fourteen (14) life science companies in place already\, the space is nearly filled to capacity\, but there may be an open spot left\, so hurry and hear from the select resident companies themselves of the benefits of being part of the emerging South of Boston innovation ecosystem. \nWe invite you to check our portfolio companies at: https://www.bioinc.org/portfolio/ \nAgenda: \n10:30 am:    Registration\, Networking and Refreshments \n11:00 am-12 noon:   Welcome (Confirmed Speakers): \n\nRuss Yukhananov\, President\, Mansfield Bio-Incubator\n\nPaul Feeney\,  Massachusetts Senator\, Representing Norfolk &Bristol\n\nRobert Coughlin\, President &CEO\, Massachusetts Biotechnology Council\n\nChristopher Gilrein\, Business Development\, Massachusetts Life Science Center\n\nMike Kennealy\, Secretary\, Executive Office of Housing and Economic Development for the Commonwealth of Massachusetts\n\n\n12:00 noon -1 pm:    Company Presentations\n\n\n1 pm-2:30 pm:    Product Demonstrations\, Continued Networking and Celebrating\, and Facility Tours\n\nPresenting companies (confirmed):\nGAMA Therapeutics is developing photodisinfection therapies and devices in combination with antimicrobial photosensitizers \nHilltop Biosciences is helping animals heal faster\, stronger using next generation allogeneic tissue-we make it easier to treat soft tissue injuries \nEightyEight Pharma is tackling the opioid epidemic by providing an innovative  Oppotoxy™ Bottle\, an opioid abuse deterrent packaging platform.
URL:https://scienceinboston.com/event/mansfield-bio-incubators-second-annual-open-house/
LOCATION:Mansfield Bio-Incubator\, 241 Francis Avenue\, Mansfield\, MA\, 02048\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191105T103000
DTEND;TZID=America/New_York:20191105T143000
DTSTAMP:20191021T134627Z
CREATED:20191021T134627Z
LAST-MODIFIED:20191021T134627Z
UID:27352-1572949800-1572964200@scienceinboston.com
SUMMARY:Mansfield Bio-Incubator's Second Annual Open House
DESCRIPTION:Overview\n\n  \nMansfield Bio-Incubator invites you to attend its second annual Open House on November 5\, 2019 in Mansfield\, Massachusetts. Come join in the fun and see how innovative startup companies are transforming the world with game-changing inventions in life science! \nOver the past year\,  we have added several new exciting startups while our resident companies have been growing and made progress in their research. \nWe are now gearing to expand beyond our 10\,000 sqft space. Up to 1M sqft of the R&D and manufacturing space is planned to house both earlier-stage and mature life science companies. In this way\, we are catalyzing the transformation of the entire 63-acre former glass bottling factory into a 21st century LIfe Science R&D and manufacturing campus. \nSee more information here! \nThis transformation is all due to the cutting edge science and product development going on in the proof of concept laboratories in the incubator.  We have nucleated the life science ecosystem South of Boston and the success is due to you! \nCome see for yourself that the biotechnology supercluster extends along the South of Boston innovation corridor right here to Mansfield\, Massachusetts. Join in the celebration and envision a future for yourself and your company alongside these pioneers. \nYou are invited to celebrate\, connect and launch! Collaborators\, investments and companies are all right here waiting to meet you. If you are working to find a cure for cancer\, detect disease earlier than ever before or treat diseases that have long been neglected\, you will find a home right here at the Mansfield Bio-Incubator. With fourteen (14) life science companies in place already\, the space is nearly filled to capacity\, but there may be an open spot left\, so hurry and hear from the select resident companies themselves of the benefits of being part of the emerging South of Boston innovation ecosystem. \nWe invite you to check our portfolio companies at: https://www.bioinc.org/portfolio/ \nAgenda: \n10:30 am:    Registration\, Networking and Refreshments \n11:00 am-12 noon:   Welcome (Confirmed Speakers): \n\nRuss Yukhananov\, President\, Mansfield Bio-Incubator\n\nPaul Feeney\,  Massachusetts Senator\, Representing Norfolk &Bristol\n\nRobert Coughlin\, President &CEO\, Massachusetts Biotechnology Council\n\nChristopher Gilrein\, Business Development\, Massachusetts Life Science Center\n\nMike Kennealy\, Secretary\, Executive Office of Housing and Economic Development for the Commonwealth of Massachusetts\n\n\n12:00 noon -1 pm:    Company Presentations\n\n\n1 pm-2:30 pm:    Product Demonstrations\, Continued Networking and Celebrating\, and Facility Tours\n\nPresenting companies (confirmed):\nGAMA Therapeutics is developing photodisinfection therapies and devices in combination with antimicrobial photosensitizers \nHilltop Biosciences is helping animals heal faster\, stronger using next generation allogeneic tissue-we make it easier to treat soft tissue injuries \nEightyEight Pharma is tackling the opioid epidemic by providing an innovative  Oppotoxy™ Bottle\, an opioid abuse deterrent packaging platform.
URL:https://scienceinboston.com/event/mansfield-bio-incubators-second-annual-open-house-2/
LOCATION:Mansfield Bio-Incubator\, 241 Francis Avenue\, Mansfield\, MA\, 02048\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T163000
DTEND;TZID=America/New_York:20191104T190000
DTSTAMP:20191021T133736Z
CREATED:20191021T133736Z
LAST-MODIFIED:20191021T133736Z
UID:6886-1572885000-1572894000@scienceinboston.com
SUMMARY:Grand Opening: Ipsen Innovation Center / Biolabs
DESCRIPTION:Description\nOn Monday\, November 4\, 2019\, Ipsen invites you to join us as we celebrate the grand opening of the Ipsen Innovation Center | Biolabs. This event will offer an overview of our new collaborative space\, provide an opportunity to meet our resident companies\, and network with friends and colleagues from across the biotech community. \nLocated in Ipsen’s North American Global Hub in Kendall Square\, the Ipsen Innovation Center | Biolabs provides a collaborative space for early-stage life sciences entrepreneurs\, researchers and investors to develop and deliver new therapies for patients\, including those with cancer\, rare diseases and neurological disorders. The Innovation Center is already home to 11 companies with additional companies preparing to move in. \nTo learn more about Ipsen and its Business Development focus\, click here. \nIf you have any questions about the event\, please contact Nick Chang at nchang@macbiocom.com. \nSpace is limited.
URL:https://scienceinboston.com/event/grand-opening-ipsen-innovation-center-biolabs/
LOCATION:Ipsen Cambridge Office\, 650 Kendall St\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T163000
DTEND;TZID=America/New_York:20191104T190000
DTSTAMP:20191021T133736Z
CREATED:20191021T133736Z
LAST-MODIFIED:20191021T133736Z
UID:27351-1572885000-1572894000@scienceinboston.com
SUMMARY:Grand Opening: Ipsen Innovation Center / Biolabs
DESCRIPTION:Description\nOn Monday\, November 4\, 2019\, Ipsen invites you to join us as we celebrate the grand opening of the Ipsen Innovation Center | Biolabs. This event will offer an overview of our new collaborative space\, provide an opportunity to meet our resident companies\, and network with friends and colleagues from across the biotech community. \nLocated in Ipsen’s North American Global Hub in Kendall Square\, the Ipsen Innovation Center | Biolabs provides a collaborative space for early-stage life sciences entrepreneurs\, researchers and investors to develop and deliver new therapies for patients\, including those with cancer\, rare diseases and neurological disorders. The Innovation Center is already home to 11 companies with additional companies preparing to move in. \nTo learn more about Ipsen and its Business Development focus\, click here. \nIf you have any questions about the event\, please contact Nick Chang at nchang@macbiocom.com. \nSpace is limited.
URL:https://scienceinboston.com/event/grand-opening-ipsen-innovation-center-biolabs-2/
LOCATION:Ipsen Cambridge Office\, 650 Kendall St\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T103000
DTEND;TZID=America/New_York:20191104T160000
DTSTAMP:20191021T132702Z
CREATED:20191021T132702Z
LAST-MODIFIED:20191021T132702Z
UID:6883-1572863400-1572883200@scienceinboston.com
SUMMARY:Manufacturing Novel Biopharmaceuticals: 6 Keys to Success
DESCRIPTION:Overview\n\nCAI is passionate about helping development and clinical stage companies bring their product to market faster. Our custom solutions integrate the elements of product\, process\, quality\, facility\, and people to enable our clients achieve milestones quickly and reliably – while avoiding missteps that can impact patient access to novel\, life-saving therapies. \nWe welcome you to join our global team of experts to explore Manufacturing Novel Biopharmaceutical Products: Six Keys to Success on November 4th at MassBio in Kendall Square. \nMorning Session topics will include: \n\nQuality Systems: Early Adoption as a Competitive Advantage – John Henchion\nQuality by Design: Accelerating Patient Access to Novel Products – Jim Lambert\nFacility Design for Cell and Gene Therapy Products: Best Practices – Bill Deckert\n\nAfternoon Session topics will include \n\nProcess Validation:  Foundation for Product Lifecycle Management – Rusty Morrison\nTechnology Transfer Project Management Best Practices – Beth Haas\nTalent Plan: Growing the Team to Hit Each Milestone – Harry Benson\nPanel Discussion:  Speed to Market – Making it Happen – All speakers\, moderated by Charlie Maher\, Director Process and Manufacturing Technology\n\nCAI will host a networking lunch between sessions and an after-work reception at Catalyst from 4:00pm – 6:30pm. \nRSVP: https://caimassbio.eventbrite.com
URL:https://scienceinboston.com/event/manufacturing-novel-biopharmaceuticals-6-keys-to-success/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T103000
DTEND;TZID=America/New_York:20191104T160000
DTSTAMP:20191021T132702Z
CREATED:20191021T132702Z
LAST-MODIFIED:20191021T132702Z
UID:27350-1572863400-1572883200@scienceinboston.com
SUMMARY:Manufacturing Novel Biopharmaceuticals: 6 Keys to Success
DESCRIPTION:Overview\n\nCAI is passionate about helping development and clinical stage companies bring their product to market faster. Our custom solutions integrate the elements of product\, process\, quality\, facility\, and people to enable our clients achieve milestones quickly and reliably – while avoiding missteps that can impact patient access to novel\, life-saving therapies. \nWe welcome you to join our global team of experts to explore Manufacturing Novel Biopharmaceutical Products: Six Keys to Success on November 4th at MassBio in Kendall Square. \nMorning Session topics will include: \n\nQuality Systems: Early Adoption as a Competitive Advantage – John Henchion\nQuality by Design: Accelerating Patient Access to Novel Products – Jim Lambert\nFacility Design for Cell and Gene Therapy Products: Best Practices – Bill Deckert\n\nAfternoon Session topics will include \n\nProcess Validation:  Foundation for Product Lifecycle Management – Rusty Morrison\nTechnology Transfer Project Management Best Practices – Beth Haas\nTalent Plan: Growing the Team to Hit Each Milestone – Harry Benson\nPanel Discussion:  Speed to Market – Making it Happen – All speakers\, moderated by Charlie Maher\, Director Process and Manufacturing Technology\n\nCAI will host a networking lunch between sessions and an after-work reception at Catalyst from 4:00pm – 6:30pm. \nRSVP: https://caimassbio.eventbrite.com
URL:https://scienceinboston.com/event/manufacturing-novel-biopharmaceuticals-6-keys-to-success-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T113000
DTEND;TZID=America/New_York:20191103T120000
DTSTAMP:20191021T132418Z
CREATED:20191021T132418Z
LAST-MODIFIED:20191021T132418Z
UID:6879-1572780600-1572782400@scienceinboston.com
SUMMARY:PurpleStride Boston 2019: Walk with Elstar Therapeutics
DESCRIPTION:Overview\n\nElstar Therapeutics is proud to be a Silver Sponsor for this year’s PurpleStride in Boston. \nPancreatic cancer has the lowest survival rate of all major cancers\, at just 9%. This deadly disease has stolen our best and our brightest\, but it can’t take away our determination. \nOur team has stepped up to Wage Hope at PurpleStride\, the walk to end pancreatic cancer. Will you help us rewrite the future of this disease by making a donation today? \nEvery dollar that you donate ensures that the Pancreatic Cancer Action Network can continue working to create better outcomes for pancreatic cancer patients and their families. By donating to our team\, you are supporting vital efforts to double pancreatic cancer survival by 2020. \nPurple ribbons aren’t enough. Please join us in the fight today. 
URL:https://scienceinboston.com/event/purplestride-boston-2019-walk-with-elstar-therapeutics/
LOCATION:Boston Common – Parkman Bandstand\, 131 Tremont St\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T113000
DTEND;TZID=America/New_York:20191103T120000
DTSTAMP:20191021T132418Z
CREATED:20191021T132418Z
LAST-MODIFIED:20191021T132418Z
UID:27349-1572780600-1572782400@scienceinboston.com
SUMMARY:PurpleStride Boston 2019: Walk with Elstar Therapeutics
DESCRIPTION:Overview\n\nElstar Therapeutics is proud to be a Silver Sponsor for this year’s PurpleStride in Boston. \nPancreatic cancer has the lowest survival rate of all major cancers\, at just 9%. This deadly disease has stolen our best and our brightest\, but it can’t take away our determination. \nOur team has stepped up to Wage Hope at PurpleStride\, the walk to end pancreatic cancer. Will you help us rewrite the future of this disease by making a donation today? \nEvery dollar that you donate ensures that the Pancreatic Cancer Action Network can continue working to create better outcomes for pancreatic cancer patients and their families. By donating to our team\, you are supporting vital efforts to double pancreatic cancer survival by 2020. \nPurple ribbons aren’t enough. Please join us in the fight today. 
URL:https://scienceinboston.com/event/purplestride-boston-2019-walk-with-elstar-therapeutics-2/
LOCATION:Boston Common – Parkman Bandstand\, 131 Tremont St\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T083000
DTEND;TZID=America/New_York:20191101T180000
DTSTAMP:20191021T131835Z
CREATED:20191021T131835Z
LAST-MODIFIED:20191021T131835Z
UID:6872-1572597000-1572631200@scienceinboston.com
SUMMARY:Activated Egg Symposium
DESCRIPTION:The Bedford Research Foundation’s Activated Egg Symposium is a world-class lecture symposium featuring thought leaders from around the globe.  This years keynote speakers include: Dr. Joseph Takahashi\, Dr. Shoukhrat Mitalipov\, Dr. Ann A Kiessling and more.  A full lunch and dinner are provided as part of the registration\, the dinner speaker is renowned ethasist Arthur Applbaum.
URL:https://scienceinboston.com/event/activated-egg-symposium/
LOCATION:Marriot Courtyard Boston Downtown\, 275 Tremont St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T083000
DTEND;TZID=America/New_York:20191101T180000
DTSTAMP:20191021T131835Z
CREATED:20191021T131835Z
LAST-MODIFIED:20191021T131835Z
UID:27347-1572597000-1572631200@scienceinboston.com
SUMMARY:Activated Egg Symposium
DESCRIPTION:The Bedford Research Foundation’s Activated Egg Symposium is a world-class lecture symposium featuring thought leaders from around the globe.  This years keynote speakers include: Dr. Joseph Takahashi\, Dr. Shoukhrat Mitalipov\, Dr. Ann A Kiessling and more.  A full lunch and dinner are provided as part of the registration\, the dinner speaker is renowned ethasist Arthur Applbaum.
URL:https://scienceinboston.com/event/activated-egg-symposium-2/
LOCATION:Marriot Courtyard Boston Downtown\, 275 Tremont St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191021T131446Z
CREATED:20191021T131446Z
LAST-MODIFIED:20191021T131446Z
UID:6868-1572595200-1572627600@scienceinboston.com
SUMMARY:Questrom’s Seventh Annual Health & Life Sciences Conference
DESCRIPTION:The Health & Life Sciences Conference is an annual\, student-organized event that brings together a diverse audience of more than 250 students and professionals across all sectors of the US healthcare industry for valuable networking and comprehensive programming spanning healthcare delivery and hospitals\, to pharmaceuticals and medical devices. \n2019 Health & Life Science Conference  \nDisruption in the Face of Limitation:\nInnovation in an Era of Consumerism and Cost Sensitivity \nAs we approach 2020\, healthcare in the United States still occupies a large percentage of the United States Gross Domestic Product. Growing healthcare expenditures remain to be forecast for the coming years. With many industries embracing disruption through innovation\, can healthcare be targeted with initiatives to creatively decrease costs in the face of rising demand? At the 7th Annual Questrom Health & Life Sciences Conference\, panelists and speakers representing diverse stakeholders in the US healthcare system will engage in discussions around topics at the center of this drive to improve value so that we may begin to understand its impact\, both present and promised. \nTo show our appreciation\, our speakers from past years’ conferences are invited to attend this year’s conference as our guests! Please email buhlsc@bu.edu to receive a code for a complimentary conference ticket.
URL:https://scienceinboston.com/event/questroms-seventh-annual-health-life-sciences-conference/
LOCATION:Questrom School of Business\, 595 Commonwealth Ave\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191021T131446Z
CREATED:20191021T131446Z
LAST-MODIFIED:20191021T131446Z
UID:27346-1572595200-1572627600@scienceinboston.com
SUMMARY:Questrom’s Seventh Annual Health & Life Sciences Conference
DESCRIPTION:The Health & Life Sciences Conference is an annual\, student-organized event that brings together a diverse audience of more than 250 students and professionals across all sectors of the US healthcare industry for valuable networking and comprehensive programming spanning healthcare delivery and hospitals\, to pharmaceuticals and medical devices. \n2019 Health & Life Science Conference  \nDisruption in the Face of Limitation:\nInnovation in an Era of Consumerism and Cost Sensitivity \nAs we approach 2020\, healthcare in the United States still occupies a large percentage of the United States Gross Domestic Product. Growing healthcare expenditures remain to be forecast for the coming years. With many industries embracing disruption through innovation\, can healthcare be targeted with initiatives to creatively decrease costs in the face of rising demand? At the 7th Annual Questrom Health & Life Sciences Conference\, panelists and speakers representing diverse stakeholders in the US healthcare system will engage in discussions around topics at the center of this drive to improve value so that we may begin to understand its impact\, both present and promised. \nTo show our appreciation\, our speakers from past years’ conferences are invited to attend this year’s conference as our guests! Please email buhlsc@bu.edu to receive a code for a complimentary conference ticket.
URL:https://scienceinboston.com/event/questroms-seventh-annual-health-life-sciences-conference-2/
LOCATION:Questrom School of Business\, 595 Commonwealth Ave\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T180000
DTEND;TZID=America/New_York:20191030T210000
DTSTAMP:20191023T174535Z
CREATED:20191023T174535Z
LAST-MODIFIED:20191023T174535Z
UID:6971-1572458400-1572469200@scienceinboston.com
SUMMARY:Imagine & Believe An Evening to Benefit NTSAD
DESCRIPTION:Overview\n\nFor 62 years\, NTSAD has been bringing together families\, researchers\, clinicians and friends in the rare disease community to share\, learn\, network\, and collaborate with a goal of building relationships and identifying treatments and potential cures for Tay-Sachs\, Sandhoff\, Canavan\, and GM1 gangliosidosis. Vital to building this community is Imagine & Believe. Held annually\, the event draws honorees and special guests who embody the wisdom of the past challenges and the vision of the possibilities in rare disease research. In 2019\, we are thrilled to honor Cynthia Tifft\, MD\, PhD\, Deputy Clinical Director of the National Human Genome Research Institute/NIH\, who has championed natural history studies to build the framework of her just-announced GM1 clinical trials.  Dr. Tifft has been a partner and close friend to NTSAD and our families since 1998. \nThe goals of Imagine & Believe include (1) connecting leaders in research\, biotech\, medicine\, clinical pursuits\, science\, and our affected families with a goal of learning from the past\, discussing the current state of rare diseases\, and building alliances and partnerships for the future\, and (2) raising vital funds for continued research\, build and steward our veteran and new partnerships\, and serve our families. \nTraditionally\, about two-thirds of attendees are strongly networked in the biotech community\, especially in rare diseases.  Other attendees include family members\, clinicians\, scientists\, and special friends of NTSAD. \nThe evening program is as follows: \n6 – 7:30       Reception\, dinner & silent auction \n7:45 – 9pm  Dessert & program
URL:https://scienceinboston.com/event/imagine-believe-an-evening-to-benefit-ntsad/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T180000
DTEND;TZID=America/New_York:20191030T210000
DTSTAMP:20191023T174535Z
CREATED:20191023T174535Z
LAST-MODIFIED:20191023T174535Z
UID:27367-1572458400-1572469200@scienceinboston.com
SUMMARY:Imagine & Believe An Evening to Benefit NTSAD
DESCRIPTION:Overview\n\nFor 62 years\, NTSAD has been bringing together families\, researchers\, clinicians and friends in the rare disease community to share\, learn\, network\, and collaborate with a goal of building relationships and identifying treatments and potential cures for Tay-Sachs\, Sandhoff\, Canavan\, and GM1 gangliosidosis. Vital to building this community is Imagine & Believe. Held annually\, the event draws honorees and special guests who embody the wisdom of the past challenges and the vision of the possibilities in rare disease research. In 2019\, we are thrilled to honor Cynthia Tifft\, MD\, PhD\, Deputy Clinical Director of the National Human Genome Research Institute/NIH\, who has championed natural history studies to build the framework of her just-announced GM1 clinical trials.  Dr. Tifft has been a partner and close friend to NTSAD and our families since 1998. \nThe goals of Imagine & Believe include (1) connecting leaders in research\, biotech\, medicine\, clinical pursuits\, science\, and our affected families with a goal of learning from the past\, discussing the current state of rare diseases\, and building alliances and partnerships for the future\, and (2) raising vital funds for continued research\, build and steward our veteran and new partnerships\, and serve our families. \nTraditionally\, about two-thirds of attendees are strongly networked in the biotech community\, especially in rare diseases.  Other attendees include family members\, clinicians\, scientists\, and special friends of NTSAD. \nThe evening program is as follows: \n6 – 7:30       Reception\, dinner & silent auction \n7:45 – 9pm  Dessert & program
URL:https://scienceinboston.com/event/imagine-believe-an-evening-to-benefit-ntsad-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T083000
DTEND;TZID=America/New_York:20191030T190000
DTSTAMP:20191023T174345Z
CREATED:20191023T174345Z
LAST-MODIFIED:20191023T174345Z
UID:6968-1572424200-1572462000@scienceinboston.com
SUMMARY:Forsyth Symposium: Immune Modulation of the Host-Microbe Interface
DESCRIPTION:Join us for the second annual Forsyth Symposium: Immune Modulation at the Host-Microbe Interface \nWhen: 8:30 am – 7 pm\, October 30th\, 2019 \nWhere: Forsyth Institute\, 1 Athenaeum St\, Cambridge\, MA 02142 \nClick here for more information and to register
URL:https://scienceinboston.com/event/forsyth-symposium-immune-modulation-of-the-host-microbe-interface/
LOCATION:Forsyth Institute\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T083000
DTEND;TZID=America/New_York:20191030T190000
DTSTAMP:20191023T174345Z
CREATED:20191023T174345Z
LAST-MODIFIED:20191023T174345Z
UID:27366-1572424200-1572462000@scienceinboston.com
SUMMARY:Forsyth Symposium: Immune Modulation of the Host-Microbe Interface
DESCRIPTION:Join us for the second annual Forsyth Symposium: Immune Modulation at the Host-Microbe Interface \nWhen: 8:30 am – 7 pm\, October 30th\, 2019 \nWhere: Forsyth Institute\, 1 Athenaeum St\, Cambridge\, MA 02142 \nClick here for more information and to register
URL:https://scienceinboston.com/event/forsyth-symposium-immune-modulation-of-the-host-microbe-interface-2/
LOCATION:Forsyth Institute\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191029T120000
DTEND;TZID=America/New_York:20191029T160000
DTSTAMP:20191023T173626Z
CREATED:20191023T173626Z
LAST-MODIFIED:20191023T173626Z
UID:6966-1572350400-1572364800@scienceinboston.com
SUMMARY:Life Sciences & Biotech Internship and Job Career Fair
DESCRIPTION:Overview\n\nRegistration for the University of Massachusetts Amherst’s fall Life Sciences Career Fair is now open at this Handshake link.  The Fair will be held on Tuesday\, October 29\, 2019 from 12:00 – 4:00 pm in our Campus Center Auditorium.  Lunch\, parking and Wi-Fi access are all included.  Take $100 off the registration fee if you reserve and pay for your table before July 1\, 2019. \nCome meet with our large and diverse cohort of talented Life Sciences students (from undergraduates through PhD’s) for your internships\, co-ops\, fellowships and full time positions.  Last year\, we had over 600 students come to this Fair to network with the companies\, and learn more about the organizations\, and we anticipate more students this year. \nUMass Amherst students can now easily stay at our Mount Ida Campus in Newton\, when doing internships and co-ops in and around the Boston area. \nPlease let me know if you have any questions about this Career Fair\, Handshake\, or recruiting UMass Amherst students. \nJanet Bordwin \nDirector\, Career & Professional Development Center \nCollege of Natural Sciences \nUniversity of Massachusetts\, Amherst \njbordwin@umass.edu; 413-545-1545
URL:https://scienceinboston.com/event/life-sciences-biotech-internship-and-job-career-fair/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191029T120000
DTEND;TZID=America/New_York:20191029T160000
DTSTAMP:20191023T173626Z
CREATED:20191023T173626Z
LAST-MODIFIED:20191023T173626Z
UID:27365-1572350400-1572364800@scienceinboston.com
SUMMARY:Life Sciences & Biotech Internship and Job Career Fair
DESCRIPTION:Overview\n\nRegistration for the University of Massachusetts Amherst’s fall Life Sciences Career Fair is now open at this Handshake link.  The Fair will be held on Tuesday\, October 29\, 2019 from 12:00 – 4:00 pm in our Campus Center Auditorium.  Lunch\, parking and Wi-Fi access are all included.  Take $100 off the registration fee if you reserve and pay for your table before July 1\, 2019. \nCome meet with our large and diverse cohort of talented Life Sciences students (from undergraduates through PhD’s) for your internships\, co-ops\, fellowships and full time positions.  Last year\, we had over 600 students come to this Fair to network with the companies\, and learn more about the organizations\, and we anticipate more students this year. \nUMass Amherst students can now easily stay at our Mount Ida Campus in Newton\, when doing internships and co-ops in and around the Boston area. \nPlease let me know if you have any questions about this Career Fair\, Handshake\, or recruiting UMass Amherst students. \nJanet Bordwin \nDirector\, Career & Professional Development Center \nCollege of Natural Sciences \nUniversity of Massachusetts\, Amherst \njbordwin@umass.edu; 413-545-1545
URL:https://scienceinboston.com/event/life-sciences-biotech-internship-and-job-career-fair-2/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191028T080000
DTEND;TZID=America/New_York:20191029T170000
DTSTAMP:20191023T173318Z
CREATED:20191023T173318Z
LAST-MODIFIED:20191023T173318Z
UID:6963-1572249600-1572368400@scienceinboston.com
SUMMARY:FierceBiotech's 4th Drug Development Forum
DESCRIPTION:The 4th FierceBiotech Drug Development Forum\, taking place on October 28–29 in Boston\, provides a unique opportunity for attendees\, highlighting C-suite and executive leadership perspectives on how to successfully discover\, develop\, and commercialize a product. Our speaking faculty will also address key business considerations\, discussing how to map out the right financing strategy for your company and sharing strategies to mitigate risks and unlock the potential of acquisitions\, licensing deals\, and partnerships.
URL:https://scienceinboston.com/event/fiercebiotechs-4th-drug-development-forum/
LOCATION:The Colonnade Hotel\, 120 Huntington Avenue\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191028T080000
DTEND;TZID=America/New_York:20191029T170000
DTSTAMP:20191023T173318Z
CREATED:20191023T173318Z
LAST-MODIFIED:20191023T173318Z
UID:27364-1572249600-1572368400@scienceinboston.com
SUMMARY:FierceBiotech's 4th Drug Development Forum
DESCRIPTION:The 4th FierceBiotech Drug Development Forum\, taking place on October 28–29 in Boston\, provides a unique opportunity for attendees\, highlighting C-suite and executive leadership perspectives on how to successfully discover\, develop\, and commercialize a product. Our speaking faculty will also address key business considerations\, discussing how to map out the right financing strategy for your company and sharing strategies to mitigate risks and unlock the potential of acquisitions\, licensing deals\, and partnerships.
URL:https://scienceinboston.com/event/fiercebiotechs-4th-drug-development-forum-2/
LOCATION:The Colonnade Hotel\, 120 Huntington Avenue\, Boston\, MA\, 02116\, United States
END:VEVENT
END:VCALENDAR